Rowley Law PLLC Investigates iTeos Therapeutics Acquisition for Securities Law Violations
ByAinvest
Monday, Jul 21, 2025 8:03 pm ET1min read
ITOS--
According to the latest press release [1], the acquisition deal, expected to close in the third quarter of 2025, offers stockholders of iTeos Therapeutics $10.047 and one contingent value right per share. The contingent value right entitles shareholders to additional shares or cash in the future, depending on the performance of Concentra Biosciences.
Shareholders interested in obtaining more information about the investigation can visit Rowley Law PLLC's website at [http://www.rowleylawpllc.com/investigation/itos/](http://www.rowleylawpllc.com/investigation/itos/) or contact Shane Rowley, Esq., at 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC specializes in representing shareholders in class actions and derivative lawsuits in complex corporate litigation. The firm has been involved in numerous high-profile cases and has a strong track record of advocating for shareholder rights.
The investigation by Rowley Law PLLC underscores the importance of thorough due diligence and transparency in corporate acquisitions. It serves as a reminder to investors to stay vigilant and seek legal advice if they suspect any irregularities in corporate transactions.
References:
[1] https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc-302509917.html
[2] https://www.marketscreener.com/news/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc-ce7c5cdcda8ef722
[3] https://www.morningstar.com/news/pr-newswire/20250721ny34377/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc
MORN--
Rowley Law PLLC is investigating iTeos Therapeutics' proposed acquisition by Concentra Biosciences for potential securities law violations. Stockholders will receive $10.047 and one contingent value right per share. The transaction is expected to close in Q3 2025. Shareholders interested in additional information can visit rowleylawpllc.com/investigation/itos.
Rowley Law PLLC has launched an investigation into potential securities law violations by iTeos Therapeutics, Inc. (NASDAQ: ITOS) and its board of directors in relation to the proposed acquisition by Concentra Biosciences, LLC. The investigation centers on whether the acquisition process has complied with relevant securities laws.According to the latest press release [1], the acquisition deal, expected to close in the third quarter of 2025, offers stockholders of iTeos Therapeutics $10.047 and one contingent value right per share. The contingent value right entitles shareholders to additional shares or cash in the future, depending on the performance of Concentra Biosciences.
Shareholders interested in obtaining more information about the investigation can visit Rowley Law PLLC's website at [http://www.rowleylawpllc.com/investigation/itos/](http://www.rowleylawpllc.com/investigation/itos/) or contact Shane Rowley, Esq., at 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC specializes in representing shareholders in class actions and derivative lawsuits in complex corporate litigation. The firm has been involved in numerous high-profile cases and has a strong track record of advocating for shareholder rights.
The investigation by Rowley Law PLLC underscores the importance of thorough due diligence and transparency in corporate acquisitions. It serves as a reminder to investors to stay vigilant and seek legal advice if they suspect any irregularities in corporate transactions.
References:
[1] https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc-302509917.html
[2] https://www.marketscreener.com/news/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc-ce7c5cdcda8ef722
[3] https://www.morningstar.com/news/pr-newswire/20250721ny34377/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-iteos-therapeutics-inc
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet